Category: News
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
- 22 04 2019
- |
EDBI continuing to invest in exciting digital health, biotech and fintech companies in Q4 2019
Q4 2019 saw EDBI continuing to invest in exciting digital health, biotech and
fintech companies which would aid our local companies in their digitalisation and
transformation
- 04 04 2019
- |